Publications

President Trump and many in Congress want to reduce prescription drug prices. This paper discusses how drug prices are determined and explains why political efforts to reduce them would be both harmful and counterproductive. 

At least some World Economic Forum attendees think we have reached "peak laissez-faire," meaning it's time to give government more control over our economies and our liberties. 

One of the president's top trade advisors sees nothing but positives from imposing tariffs. A more balanced view sees some positives, but many negatives. 

Who could imagine 10 years ago that the Middle East could be in chaos and it would have virtually no impact on gasoline prices? Welcome to the age of fracking.

The global climate change conference ends in disappointment when it becomes obvious that talk is much cheaper than actions.

The House impeachment effort is political grandstanding. Here's how you know.

Taxpayers send hundreds of billions of dollars to the federal government and then beg the feds to give some of it back. Why not eliminate the middle man?

Perhaps the day will come when a new process could supplant the FCC-led public auction process for re-purposing spectrum. But this aspiration for long-term spectrum policy is not the world we have today.

President Trump is taking steps to increase price transparency in health care. We agree with the goal, but one needs to ask why prices aren't already transparent, as they are in the rest of the economy.

The Supreme Court's Wayfair decision gave states a new revenue stream—as well as an excuse to spend even more taxpayer money.